TrialNeuro-oncology2015

A phase II trial of everolimus, temozolomide, and radiotherapy in patients with newly diagnosed glioblastoma: NCCTG N057K.

Daniel J Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.